|
|
Optimization of the Method for Scarless Gene Knockout in Escherichia coli Genome |
GE Gao-shun1, ZHANG Li-chao1, ZHAO Xin2, HU Xue-jun1, LI Ya-jie1 |
1. Medical College, Dalian University, Dalian 116622, China;
2. Liaoning Entry-Exit Inspection and Quarantine Bureau, Dalian 116001, China |
|
|
Abstract Objective: The purpose was to improve the efficiency of scarless gene knockout in E. coli genome by the optimized method. Methods: The efficacy of scarless gene knockout in E.coli genome by two steps Red homologous recombinantion system and endonuclease I-SceI screening was investigated via optimization of the homologous DNA length with target sequence and the inducer concentration for production of I-SceI for the selection of positive clones. The scarless knockout of nanKETA clusters in the strain CLM37 was taken as a model. The new strain growth behaviour with the scarless knockout of nanKETA was investigated via the comparing the growth curves of wildtype E. coli CLM37. Results: The nanKETA clusters were knockouted scarless successfully in E. coli CLM37 genome, and the efficacy of scarless processing was increased up to 90% via extending the length of the homologous DNA with the genome, from the 80 base pairs normally used up to 684 base pairs, and increasing the concentration of the inducer tetracycline for producing I-SceI, from 500 μg/ml upto 1000 μg/ml. It is shown that the knockout of nanKETA clusters in E. coli CLM37 did not impact the growth. Conclusion: The efficacy of gene scarless knockout in E.coli can be significantly improved via extending the length of the homology DNA and increasing the concentration of inducer tetracycline.
|
Received: 05 March 2014
Published: 25 June 2014
|
|
|
|
[1] Murphy K C. Use of bacteriophage lambda recombination functions to promote gene replacement in Escherichia coli. J Bacteriol, 1998, 180(8): 2063-2071.
[2] Datsenko K A, Wanner B L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A, 2000, 97(12): 6640-6645.
[3] Tischer B K, von Einem J, Kaufer B, et al. Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. Biotechniques, 2006, 40(2): 191-197.
[4] Kolisnychenko V, Plunkett G, Herring C D, et al. Engineering a reduced Escherichia coli genome. Genome Res, 2002, 12(4): 640-647.
[5] Hashimoto M, Ichimura T, Mizoguchi H, et al. Cell size and nucleoid organization of engineered Escherichia coli cells with a reduced genome. Mol Microbiol, 2005, 55(1): 137-149.
[6] Yu B J, Sung B H, Koob M D, et al. Minimization of the Escherichia coli genome using a Tn5-targeted Cre/loxP excision system. Nat Biotechnol, 2002, 20(10): 1018-1023.
[7] Pósfai G, Kolisnychenko V, Bereczki Z, et al. Markerless gene replacement in Escherichia coli stimulated by a double-strand break in the chromosome. Nucleic Acids Res, 1999, 27(22): 4409-4415.
[8] Blank K, Hensel M, Gerlach R G. Rapid and highly efficient method for scarless mutagenesis within the Salmonella enterica chromosome. PLoS One, 2011, 6(1): e15763.
[9] Serra-Moreno R, Acosta S, Hernalsteens J P, et al. Use of the lambda Red recombinase system to produce recombinant prophages carrying antibiotic resistance genes. BMC Mol Biol, 2006, 7:31.
[10] Gerlach R G, Jckel D, Hlzer S U, et al. Rapid oligonucleotide-based recombineering of the chromosome of Salmonella enterica. Appl Environ Microbiol, 2009, 75(6): 1575-1580.
[11] Fierfort N, Samain E. Genetic engineering of Escherichia coli for the economical production of sialylated oligosaccharides. J Biotechnol, 2008, 134(3-4): 261-265.
[12] Drouillard S, Mine T, Kajiwara H, et al. Efficient synthesis of 6'-sialyllactose, 6,6'-disialyllactose, and 6'-KDO-lactose by metabolically engineered E. coli expressing a multifunctional sialyltransferase from the Photobacterium sp. JT-ISH-224. Carbohydr Res, 2010, 345(10): 1394-1399.
[13] Chen X, Varki A. Advances in the biology and chemistry of sialic acids. ACS Chem Biol, 2010, 5(2): 163-176.
[14] Kawai N, Ikematsu H, Iwaki N, et al. Comparison of the effectiveness of zanamivir and oseltamivir against influenza A/H1N1, A/H3N2, and B. Clin Infect Dis, 2009, 48(7): 996-997.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|